Cargando…
Partial p53 reactivation is sufficient to induce cancer regression
BACKGROUND: Impaired p53 function is one of the central molecular features of a tumor cell and even a partial reduction in p53 activity can increase the cancer risk in mice and men. From a therapeutic perspective it is noteworthy that tumor cells often become addicted to the absence of p53 providing...
Autores principales: | Klimovich, Boris, Meyer, Laura, Merle, Nastasja, Neumann, Michelle, König, Alexander M., Ananikidis, Nikolaos, Keber, Corinna U., Elmshäuser, Sabrina, Timofeev, Oleg, Stiewe, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889716/ https://www.ncbi.nlm.nih.gov/pubmed/35232479 http://dx.doi.org/10.1186/s13046-022-02269-6 |
Ejemplares similares
-
p53 partial loss-of-function mutations sensitize to chemotherapy
por: Klimovich, Boris, et al.
Publicado: (2021) -
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
por: Klimovich, Boris, et al.
Publicado: (2019) -
Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
por: Pavlakis, Evangelos, et al.
Publicado: (2023) -
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
por: Timofeev, Oleg, et al.
Publicado: (2019) -
Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase
por: Merle, Nastasja, et al.
Publicado: (2022)